ImmunoCellular Therapeutics, Ltd. (IMUC) has 11 open-market insider trades by 5 insiders since 2012. The most active filer is Andrew Gengos, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| James G. Bender | VPProduct Development & Mfg. | — | 3 | $93K | 2013-08-29 |
| Andrew Gengos | Dir | — | 4 | $58K | 2016-12-31 |
| Anthony Gringeri | Senior VP Strategic Resources | — | 2 | $28K | 2016-03-11 |
| Gary Titus | Dir | — | 1 | $14K | 2015-09-18 |
| David Fractor | VP of Finance | — | 1 | $10K | 2016-03-11 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Andrew Gengos | President | Buy | $4K | 2015-11-30 |
| Andrew Gengos | President | Buy | $25K | 2015-02-18 |
| Anthony Gringeri | Senior VP Strategic Resources | Buy | $18K | 2015-02-18 |
| David Fractor | VP of Finance | Buy | $10K | 2015-02-18 |
| Anthony Gringeri | Senior VP Strategic Resources | Buy | $10K | 2014-08-21 |
| Andrew Gengos | President | Buy | $9K |
Companies that share insiders with IMUC, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2014-08-14 |
| Gary Titus | Director | Buy | $14K | 2013-12-20 |
| Andrew Gengos | President | Buy | $19K | 2013-12-18 |
| Richard Cowell | Director | Sell | $290K | 2013-11-25 |
| John S. Yu | Secretary | Sell | $778K | 2013-10-18 |
| John S. Yu | Secretary | Sell | $93K | 2013-10-18 |
| James G. Bender | VP & Product Development & Mfg. | Sell | $41K | 2013-08-28 |
| James G. Bender | VP Product Development & Mfg. | Sell | $25K | 2012-06-01 |
| James G. Bender | VP & Product Development & Mfg. | Sell | $27K | 2012-05-31 |